BU, Boston Medical Center Researchers Join Forces with GSK to Fight Lung Diseases
Boston-based research team will focus on understanding how dysfunctional lung epithelial cells initiate and perpetuate pulmonary fibrosis
Boston-based research team will focus on understanding how dysfunctional lung epithelial cells initiate and perpetuate pulmonary fibrosis
Study highlights the continued need for greater diversity in cancer clinical trials.
The study was led by co-corresponding authors David A. Harris, MD, PhD, and Gustavo Mostoslavsky, MD, PhD.
Researchers examined the rationale of recent randomized trial designs and results that have proven the benefit of endovascular therapy.
Study marks an important first step towards leveraging AI technology to reduce preventable harms, achieve better healthcare outcomes.
This one-of-a-kind resource allows for studies of human longevity and resilience that can fuel the discovery and validation of novel therapeutics for aging-related disease.
Ivana Delalle, MD, PhD, professor of pathology & laboratory medicine, is one of four senior authors of these papers.
The leadership transitions will be effective Oct. 1.
Anderson is a board-certified healthcare architect and geriatrician.
Findings to serve as a reference for users and clinicians.